INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol

BACKGROUND: The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β (Aβ) plaques and neurofibrillary tangles in the absence of symptomatic cognitive or functional decline. The duration of this preclinical stage in part depends on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moga, Daniela C., Beech, Brooke F., Abner, Erin L., Schmitt, Frederick A., El Khouli, Riham H., Martinez, Ashley I., Eckmann, Lynne, Huffmyer, Mark, George, Rosmy, Jicha, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937673/
https://www.ncbi.nlm.nih.gov/pubmed/31888732
http://dx.doi.org/10.1186/s13063-019-3993-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937673/
https://www.ncbi.nlm.nih.gov/pubmed/31888732
http://dx.doi.org/10.1186/s13063-019-3993-0

Ejemplares similares